Stock Analysis

Illumina (NASDAQ:ILMN) Strong Profits May Be Masking Some Underlying Issues

NasdaqGS:ILMN 1 Year Share Price vs Fair Value
NasdaqGS:ILMN 1 Year Share Price vs Fair Value
Explore Illumina's Fair Values from the Community and select yours

Illumina, Inc.'s (NASDAQ:ILMN ) stock didn't jump after it announced some healthy earnings. Our analysis showed that there are some concerning factors in the earnings that investors may be cautious of.

earnings-and-revenue-history
NasdaqGS:ILMN Earnings and Revenue History August 8th 2025
Advertisement

The Impact Of Unusual Items On Profit

Importantly, our data indicates that Illumina's profit received a boost of US$1.0b in unusual items, over the last year. We can't deny that higher profits generally leave us optimistic, but we'd prefer it if the profit were to be sustainable. When we analysed the vast majority of listed companies worldwide, we found that significant unusual items are often not repeated. And that's as you'd expect, given these boosts are described as 'unusual'. Illumina had a rather significant contribution from unusual items relative to its profit to June 2025. All else being equal, this would likely have the effect of making the statutory profit a poor guide to underlying earnings power.

That might leave you wondering what analysts are forecasting in terms of future profitability. Luckily, you can click here to see an interactive graph depicting future profitability, based on their estimates.

Our Take On Illumina's Profit Performance

As we discussed above, we think the significant positive unusual item makes Illumina's earnings a poor guide to its underlying profitability. As a result, we think it may well be the case that Illumina's underlying earnings power is lower than its statutory profit. On the bright side, the company showed enough improvement to book a profit this year, after losing money last year. The goal of this article has been to assess how well we can rely on the statutory earnings to reflect the company's potential, but there is plenty more to consider. If you'd like to know more about Illumina as a business, it's important to be aware of any risks it's facing. Every company has risks, and we've spotted 2 warning signs for Illumina (of which 1 can't be ignored!) you should know about.

This note has only looked at a single factor that sheds light on the nature of Illumina's profit. But there are plenty of other ways to inform your opinion of a company. Some people consider a high return on equity to be a good sign of a quality business. While it might take a little research on your behalf, you may find this free collection of companies boasting high return on equity, or this list of stocks with significant insider holdings to be useful.

New: AI Stock Screener & Alerts

Our new AI Stock Screener scans the market every day to uncover opportunities.

• Dividend Powerhouses (3%+ Yield)
• Undervalued Small Caps with Insider Buying
• High growth Tech and AI Companies

Or build your own from over 50 metrics.

Explore Now for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

About NasdaqGS:ILMN

Illumina

Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.

Excellent balance sheet and good value.

Advertisement